During cancer development and progression, glycolysis and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) played an important role, such as in colorectal adenocarcinoma (Brzozowa-Zasada et al., 2018) and breast cancer (Goes et al., 2010). Here, GAPDH is linked to breast carcinoma.